ライフサイエンスコーパス: complete Freund's adjuvant

1 intraperitoneally with sheep IgG (0.2 mg in complete Freund's adjuvant).

2 ally unresponsive to rechallenge with OVA in complete Freund's adjuvant.

3 tar administration of capsaicin, formalin or complete Freund's adjuvant.

4 ia were induced by intraplantar injection of complete Freund's adjuvant.

5 were also tolerant to challenge with OVA in complete Freund's adjuvant.

6 munized with 1 mg of immunogen emulsified in complete Freund's adjuvant.

7 on of two inflammatory stimuli, formalin and complete Freund's adjuvant.

8 nses in animals immunized with ovalbumin and complete Freund's adjuvant.

9 subcutaneous injections of CM emulsified in complete Freund's adjuvant.

10 week-old animals with recombinant phogrin in complete Freund's adjuvant.

11 ation with this epitope when administered in complete Freund's adjuvant.

12 r retinoid-binding protein (IRBP) mixed with complete Freund's adjuvant.

13 nt animals were immunized with ovalbumin and complete Freund's adjuvant.

14 similar to that seen in mice immunized with complete Freund's adjuvant.

15 number of routes and even in the presence of complete Freund's adjuvant.

16 e footpad injection of P gamma emulsified in complete Freund's adjuvant.

17 ent containing the 36 kDa protein (p-36) and complete Freund's adjuvant.

18 pinal neurons during inflammation induced by complete Freund's adjuvant.

19 s of age with 100 micrograms of rgp120SF2 in complete Freund's adjuvant.

20 ced cutaneous mechanical pain in response to Complete Freund's Adjuvant.

21 proteolipid protein peptide (PLP139-151) and complete Freund's adjuvant.

22 iltration of myeloid cells upon injection of complete Freund's adjuvant.

23 s following immunization with OVA protein in complete Freund's adjuvant.

24 on with alpha-myosin heavy chain peptide and complete Freund's adjuvant.

25 by immunization with PLP(139-151) peptide in complete Freund's adjuvant.

26 lipopolysaccharide, aluminium hydroxide and complete Freund's adjuvant.

27 on of the rat hindpaw 2 d after injection of complete Freund's adjuvant.

28 oreceptor retinoid-binding protein (IRBP) in complete Freund's adjuvant.

29 mplex mixture of antigens which characterize Complete Freund's Adjuvant.

30 RT1(u).A (HLA-A-like) peptides emulsified in complete Freund's adjuvant 7 d before transplantation (n

31 sponses and paw swelling to paw injection of complete Freund's adjuvant, a model of peripheral inflam

32 Control group) or ovalbumin (OVA group) plus Complete Freund's Adjuvant administered subcutaneously o

33 d by peripheral nerve injury or injection of Complete Freund's Adjuvant, although they display intact

34 f rats following a subcutaneous injection of complete Freund's adjuvant, an inducer of chronic inflam

35 Brazil-derived protein extract emulsified in complete Freund's adjuvant and found that these mice dev

36 dilution of sera from immunized mice in the complete Freund's adjuvant and Montanide ISA51 groups an

37 -associated antigen (MAA) and two adjuvants (complete Freund's adjuvant and purified pertussis toxin)

38 r soluble antigen, with or without adjuvant (complete Freund's adjuvant and purified pertussis toxin)

39 GAT211 suppressed allodynia induced by complete Freund's adjuvant and the chemotherapeutic agen

40 ient mice were primed in vivo with ovalbumin-complete Freund's adjuvant and then restimulated ex vivo

41 is model by immunization with an emulsion of complete Freund's adjuvant and type II collagen (CII).

42 ial of mAb12D4 was assessed in the formalin, complete Freund's adjuvant, and visceral pain models.

43 In the complete Freund's adjuvant- and carrageenan-induced ther

44 After challenge with HEL-complete Freund's adjuvant as adults, immunoglobulin (Ig

45 Select CpG ODN were as effective as complete Freund's adjuvant at inducing an antigen-specif

46 Animals were immunized with complete Freund's adjuvant at the tail base.

47 ats inflamed by an intraplantar injection of complete Freund's adjuvant (CFA) 48 hr earlier (p < 0.00

48 e dose with antigen, compared favorably with complete Freund's adjuvant (CFA) and alum in eliciting t

49 itude increases in population activity after complete Freund's adjuvant (CFA) and insufficient eviden

50 a soluble culture filtrate antigen (CneF) in complete Freund's adjuvant (CFA) and the other heat-kill

51 Rodents immunized with complete Freund's adjuvant (CFA) are resistant to subseq

52 ammatory pain: (i) intraplantar injection of complete Freund's adjuvant (CFA) as a model of adjuvant-

53 ing of 17 NH2-terminal aminoacids of MBP) in complete Freund's adjuvant (CFA) causes paralysis.

54 immunized with Arg(12) mutant ras peptide in complete Freund's adjuvant (CFA) develop T cells within

55 ultiple sclerosis (MS), relies on the use of complete Freund's adjuvant (CFA) emulsions.

56 d with PEC harvested from mice injected with complete Freund's adjuvant (CFA) enhanced type-1 cytokin

57 unized with a uveitogenic regimen of IRBP in complete Freund's adjuvant (CFA) exhibited CD25+ regulat

58 e immunized with a single dose of vaccine in complete Freund's adjuvant (CFA) generated antigen-speci

59 sal roots isolated from rats with or without complete Freund's adjuvant (CFA) hindpaw inflammation, i

60 sal root, obtained from rats with or without complete Freund's adjuvant (CFA) hindpaw inflammation.

61 agnitude more efficient than free peptide in complete Freund's adjuvant (CFA) in inducing T cell acti

62 inflammatory injury induced by injection of complete Freund's adjuvant (CFA) in one hindpaw.

63 on of an inflammatory injury by injection of complete Freund's adjuvant (CFA) in one hindpaw.

64 tory pain induced by unilateral injection of complete Freund's adjuvant (CFA) in the hindpaw of male

65 sensitization in mice and rats by injecting complete Freund's adjuvant (CFA) in the hindpaw.

66 ion was induced by intradermal injections of complete Freund's adjuvant (CFA) in the left leg.

67 studies, persistent inflammation induced by complete Freund's adjuvant (CFA) increased GABAergic min

68 n rats and dose-dependently potently reduced complete Freund's adjuvant (CFA) induced chronic inflamm

69 cts of BAY-1797 were demonstrated in a mouse complete Freund's adjuvant (CFA) inflammatory pain model

70 erated recovery from inflammatory pain after complete Freund's adjuvant (CFA) injection.

71 rons during hindlimb inflammation induced by complete Freund's adjuvant (CFA) injections in the hindp

72 Complete Freund's Adjuvant (CFA) injections into the hin

73 wal latencies were measured hourly following complete Freund's adjuvant (CFA) injections.

74 Injection of complete Freund's adjuvant (CFA) into a hindpaw produced

75 model inflammation induced TMDM we injected complete Freund's adjuvant (CFA) into masseter muscle (M

76 Using this model, induced by injecting complete Freund's adjuvant (CFA) into one hind paw, we s

77 lus, was induced by subcutaneously injecting complete Freund's adjuvant (CFA) into the hind paws of r

78 heral inflammation, induced by injections of complete Freund's adjuvant (CFA) into the hindpaw.

79 ion was induced by a unilateral injection of complete Freund's adjuvant (CFA) into the masseter muscl

80 thermal hypersensitivity after injection of complete Freund's adjuvant (CFA) into the mouse hind paw

81 IP was induced by injection of Complete Freund's Adjuvant (CFA) into the plantar surfac

82 ult male rats were injected bilaterally with complete Freund's adjuvant (CFA) into the TMJ or served

83 Immunotherapy with Complete Freund's adjuvant (CFA) is effective in amelior

84 To this end, the complete Freund's adjuvant (CFA) model of inflammation w

85 d to reduced thermal hypersensitivity in the complete Freund's adjuvant (CFA) model of inflammatory p

86 ted against inflammatory hyperalgesia in the complete Freund's adjuvant (CFA) model.

87 cate that persistent inflammation induced by Complete Freund's adjuvant (CFA) modulates GABA signalin

88 ls attenuated mechanical hyperalgesia in the complete Freund's adjuvant (CFA) mouse model of inflamma

89 ized the low-pathology BL/6 mice with SEA in complete Freund's adjuvant (CFA) once before, and once a

90 established mechanical allodynia induced by complete Freund's adjuvant (CFA) or by partial sciatic n

91 mmunization with ovalbumin administered with complete Freund's adjuvant (CFA) or CFA alone.

92 ection of myelin basic protein emulsified in complete Freund's adjuvant (CFA) or passively by the tra

93 at induces the protective response, CneF, in complete Freund's adjuvant (CFA) or the immunogen that i

94 splant through preinjection with beta-gal in complete Freund's adjuvant (CFA) or through preinjection

95 d after intra-TMJ injection of a low dose of complete Freund's adjuvant (CFA) or vehicle (sham).

96 Hindpaw intraplantar injection of complete Freund's adjuvant (CFA) produced peripheral inf

97 tory pain in rodents by hindpaw injection of complete Freund's adjuvant (CFA) produces anhedonia and

98 How strong adjuvants such as complete Freund's adjuvant (CFA) promote T cell priming

99 occal surface adhesin A (PsaA) emulsified in complete Freund's adjuvant (CFA) provides protection aga

100 Injection of complete Freund's adjuvant (CFA) served as a model for i

101 After 3-4 weeks on their respective diets, complete Freund's adjuvant (CFA) was injected in one hin

102 Seven days after PTX, complete Freund's adjuvant (CFA) was injected into the p

103 study, we used a model of arthritis in which complete Freund's adjuvant (CFA) was injected into the r

104 Complete Freund's adjuvant (CFA) was injected unilateral

105 Complete Freund's adjuvant (CFA) was used to induce infl

106 sitivity induced by intraplanar injection of complete Freund's adjuvant (CFA) with efficacy comparabl

107 ubcutaneously injection of (1) GA mixed with complete Freund's adjuvant (CFA), (2) CFA alone, or (3)

108 similar to the epitope peptide delivered in complete Freund's adjuvant (CFA), and IgM production was

109 s before injection of an inflammatory agent, complete Freund's adjuvant (CFA), into the masseter musc

110 ctive at inducing liver histologic change as complete Freund's adjuvant (CFA), the standard adjuvant

111 id-binding protein1-20 peptide (IRBP1-20) in complete Freund's adjuvant (CFA), with or without a prec

112 lantar injection of formalin, carrageenan or complete Freund's adjuvant (CFA), without affecting basa

113 investigated in the K/BxN serum-transfer and complete Freund's adjuvant (CFA)-evoked active immunizat

114 ivation of the mTOR signaling pathway during complete Freund's adjuvant (CFA)-induced chronic inflamm

115 In complete Freund's adjuvant (CFA)-induced chronic inflamm

116 ATP currents in DRG neurons dissociated from complete Freund's adjuvant (CFA)-induced inflamed rats.

117 The major findings were that 48 h following complete Freund's adjuvant (CFA)-induced inflammation, t

118 re we examined the relative contributions of complete Freund's adjuvant (CFA)-induced inflammatory pa

119 ly attenuates inflammatory hyperalgesia in a complete Freund's adjuvant (CFA)-induced inflammatory pa

120 ic effects of electroacupuncture (EA) in the complete Freund's adjuvant (CFA)-induced mouse model.

121 and conditional deletion of Orai1 attenuates complete Freund's adjuvant (CFA)-induced pain hypersensi

122 or conditional deletion of Orai1 attenuates Complete Freund's adjuvant (CFA)-induced pain hypersensi

123 or G9a-specific siRNA, substantially reduced complete Freund's adjuvant (CFA)-induced pain hypersensi

124 We report that complete Freund's adjuvant (CFA)-induced peripheral infl

125 orphin (PPD) mRNA than did the adults during complete Freund's adjuvant (CFA)-induced peripheral infl

126 in the mouse formalin assay and also reduced complete Freund's adjuvant (CFA)-induced thermal hyperal

127 The 3d mutation slightly reduced complete Freund's adjuvant (CFA)-mediated antigen presen

128 MOG35-55 or MOG40-54 peptides emulsified in complete Freund's adjuvant (CFA).

129 ter injections of pertussis toxin (PTx) plus complete Freund's adjuvant (CFA).

130 al inflammation was induced by injections of complete Freund's adjuvant (CFA).

131 d in Lewis rats with myelin basic protein in complete Freund's adjuvant (CFA).

132 mation produced by intraplantar injection of complete Freund's adjuvant (CFA).

133 californica acetylcholine receptor (AChR) in complete Freund's adjuvant (CFA).

134 an cytochrome P450 (CYP) 2D6 emulsified with complete Freund's adjuvant (CFA).

135 ain was induced by intraplantar injection of complete Freund's adjuvant (CFA).

136 ce before and after hind paw inflammation by complete Freund's adjuvant (CFA).

137 produced by intraplantar (ipl) injection of complete Freund's adjuvant (CFA).

138 tein kallikrein 1b22 (Klk1b22) emulsified in complete Freund's adjuvant (CFA).

139 l of inflammatory pain, which was induced by complete Freund's adjuvant (CFA).

140 ry pain induced by intraplantar injection of complete Freund's adjuvant (CFA).

141 glycoprotein peptide 35-55 (MOG peptide) in complete Freund's adjuvant (CFA).

142 inflammation induced by hindpaw injection of complete Freund's adjuvant (CFA): artemin expression inc

143 d, or 5-6 d after intraplantar injection of Complete Freund's Adjuvant (CFA)].

144 to that conferred by yMSP1(19) emulsified in complete Freund's adjuvant (CFA/incomplete Freund's adju

145 d rats following paw inflammation induced by complete Freund's adjuvant (CFA; 1:1 injected s.c. in a

146 formalin (8-60 min), carrageenan (3 hr), and complete Freund's adjuvant (CFA; 3 d) into the rat hindp

147 ulture filtrate antigen (CneF) emulsified in complete Freund's adjuvant (CneF-CFA).

148 mmunization with schistosome egg antigens in complete Freund's adjuvant, coinfection with the nematod

149 On day 5 after injection of complete Freund's adjuvant containing heat-killed Mycoba

150 rium tuberculosis, an essential component of complete Freund's adjuvant, converted CD11b(hi)CD11c(-)

151 elin oligodendrocyte glycoprotein peptide in complete Freund's adjuvant, correlating with milder expe

152 Mice immunized with a P55 fusion protein in complete Freund's adjuvant developed anti-P55 antibodies

153 isease by injection of donor splenocytes and complete Freund's adjuvant eliminates autoimmunity and p

154 When WEB2170 was added to OVA in complete Freund's adjuvant, enhanced IgG2a but not IgG1

155 xn1(nu)) were immunized with IRBP mixed with complete Freund's adjuvant; eyes were enucleated on day

156 e given intradermal injections of gliadin in complete Freund's adjuvant (immunization) or of soluble

157 zed by the subcutaneous route with rHag B in complete Freund's adjuvant, immunized with rHag B and or

158 pon subsequent challenge with the peptide in complete Freund's adjuvant in adult life, although this

159 n spinal cord slices from rats injected with complete Freund's adjuvant in one hindpaw and from uninf

160 at reducing thermal hyperalgesia induced by complete Freund's adjuvant in rats (MED = 1 mg/kg, p.o).

161 t preventing thermal hyperalgesia induced by complete Freund's adjuvant in rats.

162 evelops in A/J mice immunized with myosin in complete Freund's adjuvant in that myosin-specific antib

163 ion was induced by subcutaneous injection of Complete Freund's Adjuvant in the left hind paw of Sprag

164 gen-specific IgG responses when immunized in complete Freund's adjuvant, indicating that B7-1 and B7-

165 TMEV infection and not when administered in complete Freund's adjuvant, indicating that molecular mi

166 munization of transgenic animals with MBP in complete Freund's adjuvant induced IFN-gamma-secreting T

167 c T cells, and immunization with antigen and complete Freund's adjuvant induced interferon-gamma-secr

168 tion of mice with myocarditogenic peptide in complete Freund's adjuvant induced the infiltration of I

169 ate (the agonist of TRPA1) and reversed CFA (Complete Freund's Adjuvant)-induced inflammation and the

170 for formalin-induced spontaneous behaviors, complete Freund's adjuvant-induced heat and mechanical h

171 FA (complete Freund's adjuvant), intradermal complete Freund's adjuvant-induced hindlimb inflammation

172 rable antinociceptive effects, including the complete Freund's adjuvant-induced inflammatory von Frey

173 ic mouse models of SCD and cancer as well as complete Freund's adjuvant-induced pain.

174 mined cFos-like immunoreactivity in a rodent complete Freund's adjuvant-induced peripheral inflammato

175 endently (ED50 = 30 micromolkg s.c.) reduced complete Freund's adjuvant-induced thermal hyperalgesia

176 n chronic pain models, we found no change in Complete Freund's adjuvant-induced thermal or mechanical

177 Using the complete Freund's Adjuvant inflammatory pain model, we s

178 zed with bovine collagen (CII) emulsified in complete Freund's adjuvant inhibited T helper type 1 dif

179 and thermal hyperalgesia after intraplantar complete Freund's adjuvant injection (ED(50) = 41 mg/kg,

180 tly reversed thermal hyperalgesia induced by complete Freund's adjuvant injection and reduced respons

181 , the late phase inflammatory pain following complete Freund's adjuvant injection and the late phase

182 is dramatically increased within 24 h of the complete Freund's adjuvant injection.

183 Inflammation was produced by injection of complete Freund's adjuvant into one hindpaw in rats, and

184 s before injection of an inflammatory agent, complete Freund's adjuvant, into the masseter muscle and

185 lammation-inducing chromic gut; and (4) CFA (complete Freund's adjuvant), intradermal complete Freund

186 interphotoreceptor retinoid-binding protein/complete Freund's adjuvant (IRBP/CFA) or adoptive transf

187 ed by peripheral inflammation (intraplanatar complete Freund's adjuvant) is substantially diminished

188 cts early cytokine expression in response to complete Freund's adjuvant-mediated inflammation.

189 hemical analysis of allografts from vimentin/complete Freund's adjuvant mice demonstrated increased n

190 7A exhibited antiallodynic efficacy in a rat complete Freund's adjuvant model for inflammatory pain s

191 Several agonists were active in the complete Freund's adjuvant model of chronic inflammatory

192 Complete Freund's Adjuvant model of cutaneous pain was u

193 sitivity in the tail immersion assay, in the complete Freund's adjuvant model of inflammatory pain an

194 nsection model of neuropathic pain or in the Complete Freund's adjuvant model of inflammatory pain.

195 ch were effective in spared nerve injury and complete Freund's adjuvant models, respectively, but fai

196 plantar injection of capsaicin, formalin, or complete Freund's adjuvant more effectively than unconju

197 T cells (DO11.10) along with OVA peptide and complete Freund's adjuvant, observing a dramatic increas

198 lymphoid cells are seen after injection with complete Freund's adjuvant or malaria infection.

199 Using an inflammatory (complete Freund's adjuvant) or neuropathic (spared nerve

200 Unilateral hind paw injections of complete Freund's adjuvant produced inflammation, hypera

201 Eluates from donor hearts placed in vimentin/complete Freund's adjuvant recipients contained anti-vim

202 aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact.

203 Prepriming of recipients with beta-gal in complete Freund's adjuvant resulted in an increased freq

204 tion of C57BL/6 mice with murine vimentin in complete Freund's adjuvant resulted in anti-vimentin ant

205 Immunization of Aotus monkeys with BVp42 in complete Freund's adjuvant resulted in high antibody tit

206 Injection of complete Freund's adjuvant resulted in inflammation and

207 immunized with soluble B. malayi antigen and complete Freund's adjuvant resulted in significantly few

208 ation with schistosome egg antigens (SEA) in complete Freund's adjuvant (SEA/CFA) correlates with ele

209 umin/alum sensitized compared with ovalbumin/complete Freund's adjuvant sensitized (p < or = 0.01).

210 three Aotus monkeys immunized with BVp42 in complete Freund's adjuvant showed evidence of protection

211 By adoptive transfer and complete Freund's adjuvant stimulation experiments, we d

212 Inflammatory pain was induced by injecting complete Freund's adjuvant subcutaneously into one hind

213 her titer of antigen-specific IgG2a than did complete Freund's adjuvant, suggesting an enhanced TH1 r

214 ven if challenged with antigen emulsified in complete Freund's adjuvant, the overall pattern was simi

215 zed to ovalbumin with alum or ovalbumin with complete Freund's adjuvant to induce T helper type 2 or

216 terphotoreceptor retinoid-binding protein in complete Freund's adjuvant to test their efficacy in sup

217 rats by injecting mycobacterium cell wall in complete Freund's adjuvant using standard techniques.

218 ermal and mechanical hyperalgesia induced by complete Freund's adjuvant was accompanied by C5a upregu

219 ls activated with intraperitoneal antigen in complete Freund's adjuvant was examined.

220 ese epitopes when injected subcutaneously in complete Freund's adjuvant was significantly enhanced if

221 le SJL/J mice and mice immunized with saline-complete Freund's adjuvant were used as controls.

222 -15 days earlier with proteolipid protein in complete Freund's adjuvant, were injected with 3 x 10(6)

223 on of two inflammatory stimuli, formalin and complete Freund's adjuvant, were reduced or abolished in

224 me of these models require immunization with complete Freund's adjuvant, whereas others suggest that

225 plex is more potent than that obtained using Complete Freund's Adjuvant with gp100, whereas no respon

226 ic challenge containing guinea pig myelin in complete Freund's adjuvant with or without KLH.